| Sara M Spivak, MA CCC-SLP | |
|
2000 Medical Pkwy, Belcher Pavilion, Suite 404, Annapolis, MD 21401 | |
| (443) 481-1140 | |
| (443) 481-1148 |
| Full Name | Sara M Spivak |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2000 Medical Pkwy, Annapolis, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295288835 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 08231 (Maryland) | Primary |
| Provider Name | Lhmg Physical Therapy, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1396122842 PECOS PAC ID: 3870893738 Enrollment ID: O20151201000903 |
News Archive
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office has allowed claims in a patent application (US Serial No. 12/550,579) derived from the "Tuschl III" patent series. The allowed claims relate to human microRNA miR-155, a microRNA that is a potential target for immuno-inflammatory indications, and a lead program of the Regulus-GSK Strategic Alliance.
An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac procedure such as a coronary stent implantation found that only three of the tests were associated with a modest ability to predict outcomes such as heart attack or death, according to a study in the February 24 issue of JAMA.
Marilyn Tavenner, acting administrator and chief operating officer of the Centers for Medicare & Medicaid Services and Caya Lewis, chief of staff at the Centers for Medicare & Medicaid Services will take part in a Web chat Wednesday, May 26, to discuss how America's Medicare recipients will benefit from the Affordable Care Act and discuss how it will reduce costs and give people more control over their health insurance.
The First Amendment protects the speech of short, elderly women and large and intimidating men equally, but you would be forgiven for thinking otherwise after oral arguments before the Supreme Court Wednesday morning.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sara M Spivak, MA CCC-SLP 2000 Medical Pkwy, Belcher Pavilion, Suite 404, Annapolis, MD 21401-3742 Ph: () - | Sara M Spivak, MA CCC-SLP 2000 Medical Pkwy, Belcher Pavilion, Suite 404, Annapolis, MD 21401 Ph: (443) 481-1140 |
News Archive
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office has allowed claims in a patent application (US Serial No. 12/550,579) derived from the "Tuschl III" patent series. The allowed claims relate to human microRNA miR-155, a microRNA that is a potential target for immuno-inflammatory indications, and a lead program of the Regulus-GSK Strategic Alliance.
An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac procedure such as a coronary stent implantation found that only three of the tests were associated with a modest ability to predict outcomes such as heart attack or death, according to a study in the February 24 issue of JAMA.
Marilyn Tavenner, acting administrator and chief operating officer of the Centers for Medicare & Medicaid Services and Caya Lewis, chief of staff at the Centers for Medicare & Medicaid Services will take part in a Web chat Wednesday, May 26, to discuss how America's Medicare recipients will benefit from the Affordable Care Act and discuss how it will reduce costs and give people more control over their health insurance.
The First Amendment protects the speech of short, elderly women and large and intimidating men equally, but you would be forgiven for thinking otherwise after oral arguments before the Supreme Court Wednesday morning.
› Verified 9 days ago
Fran L Silverman, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Anne Caverly, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Taylor Falatach, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 Williams Dr, Annapolis, MD 21401 Phone: 609-519-1954 | |
Mrs. Betty Chan-brown, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 190 Admiral Cochrane Dr, Suite 180, Annapolis, MD 21401 Phone: 410-571-6411 Fax: 410-571-6415 | |
Mrs. Judith Ann Wildner, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Rajavi Sanghavi, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 900 Van Buren St, Annapolis, MD 21403 Phone: 410-267-8653 Fax: 877-828-2060 | |
Victoria Washington-harper, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 |